Equities research analysts expect Motus GI Holdings Inc (NASDAQ:MOTS) to post earnings per share of ($0.30) for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Motus GI’s earnings. The lowest EPS estimate is ($0.31) and the highest is ($0.28). Motus GI posted earnings per share of ($0.27) in the same quarter last year, which suggests a negative year-over-year growth rate of 11.1%. The business is scheduled to announce its next quarterly earnings results on Tuesday, August 13th.
On average, analysts expect that Motus GI will report full-year earnings of ($1.13) per share for the current fiscal year, with EPS estimates ranging from ($1.25) to ($1.04). For the next year, analysts expect that the company will post earnings of ($0.86) per share, with EPS estimates ranging from ($1.36) to ($0.60). Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that follow Motus GI.
Motus GI (NASDAQ:MOTS) last released its quarterly earnings data on Friday, May 10th. The company reported ($0.29) EPS for the quarter, hitting analysts’ consensus estimates of ($0.29).
Motus GI stock opened at $3.51 on Monday. The firm has a market capitalization of $83.44 million, a price-to-earnings ratio of -2.85 and a beta of 2.03. The company has a debt-to-equity ratio of 0.05, a current ratio of 6.36 and a quick ratio of 6.31. Motus GI has a 12 month low of $2.34 and a 12 month high of $10.66.
Hedge funds and other institutional investors have recently bought and sold shares of the business. RTW Investments LP raised its holdings in Motus GI by 672.5% during the 4th quarter. RTW Investments LP now owns 459,478 shares of the company’s stock worth $1,429,000 after buying an additional 400,000 shares during the period. Nantahala Capital Management LLC acquired a new position in shares of Motus GI in the 4th quarter valued at about $1,555,000. Perceptive Advisors LLC grew its stake in shares of Motus GI by 14.2% in the 4th quarter. Perceptive Advisors LLC now owns 3,210,542 shares of the company’s stock valued at $9,984,000 after buying an additional 400,000 shares in the last quarter. Eaton Vance Management grew its stake in shares of Motus GI by 75.0% in the 4th quarter. Eaton Vance Management now owns 70,000 shares of the company’s stock valued at $218,000 after buying an additional 30,000 shares in the last quarter. Finally, Maven Securities LTD bought a new stake in shares of Motus GI in the 4th quarter valued at approximately $167,000. Hedge funds and other institutional investors own 35.30% of the company’s stock.
Motus GI Company Profile
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Featured Article: How To Calculate Debt-to-Equity Ratio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.